Altium Capital Management LP Makes New $1.85 Million Investment in Second Sight Medical Products, Inc. (NASDAQ:EYES)

Altium Capital Management LP acquired a new position in shares of Second Sight Medical Products, Inc. (NASDAQ:EYES) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 373,867 shares of the medical device company’s stock, valued at approximately $1,847,000. Altium Capital Management LP owned about 0.99% of Second Sight Medical Products as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also bought and sold shares of EYES. GWM Advisors LLC acquired a new position in shares of Second Sight Medical Products during the 2nd quarter worth about $60,000. LPL Financial LLC acquired a new position in shares of Second Sight Medical Products during the 2nd quarter worth about $61,000. Cambridge Investment Research Advisors Inc. acquired a new position in shares of Second Sight Medical Products during the 2nd quarter worth about $80,000. XTX Topco Ltd acquired a new position in shares of Second Sight Medical Products during the 1st quarter worth about $103,000. Finally, Goldman Sachs Group Inc. acquired a new position in shares of Second Sight Medical Products during the 1st quarter worth about $109,000. 9.83% of the stock is owned by institutional investors and hedge funds.

Shares of NASDAQ EYES traded up $0.01 during trading hours on Thursday, hitting $3.00. 4,800 shares of the company’s stock were exchanged, compared to its average volume of 10,228,614. Second Sight Medical Products, Inc. has a 1-year low of $0.72 and a 1-year high of $20.00. The company’s 50-day moving average price is $3.48 and its 200-day moving average price is $5.03.

About Second Sight Medical Products

Second Sight Medical Products, Inc engages in the development, manufacture, and marketing of implantable visual prosthetics. It offers Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device intended to provide artificial vision to individuals who are blind due to a wide range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury.

Featured Story: Hang Seng Index (HSI)

Want to see what other hedge funds are holding EYES? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Second Sight Medical Products, Inc. (NASDAQ:EYES).

Institutional Ownership by Quarter for Second Sight Medical Products (NASDAQ:EYES)

Receive News & Ratings for Second Sight Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Second Sight Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.